Color Doppler velocimetry and three-dimensional color power angiography of cervical carcinoma

Ultrasound in Obstetrics and Gynecology

Volumn 24, Issue 4, 2004, Pages 445-452

  Testa, A C ^a   Ferrandina, G ^a   Distefano, M ^a   Fruscella, E ^a   Mansueto, D ^a   Basso, D ^a   Salutari, V ^a   Scambia, G ^b  

^a CATHOLIC UNIVERSITY   (Italy)

^b CATHOLIC UNIVERSITY   (Italy)

Author keywords

Angiogenesis; Cervical cancer; Three dimensional power Doppler; Three dimensional ultrasound; Transvaginal color Doppler; Transvaginal ultrasound

Indexed keywords

ANTIGEN; BIOLOGICAL FACTOR; CYCLOOXYGENASE 2;

ADULT; AGED; ANGIOGRAPHY; ARTICLE; BLOOD FLOW; BLOOD LEVEL; BLOOD VESSEL; CANCER INVASION; CANCER STAGING; COLOR; COLOR ULTRASOUND FLOWMETRY; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCORING SYSTEM; SQUAMOUS CELL CARCINOMA; THREE DIMENSIONAL IMAGING; TISSUE SECTION; TUMOR VOLUME; UTERINE CERVIX CARCINOMA; VELOCITY;

ADULT; AGED; AGED, 80 AND OVER; ANGIOGRAPHY; BLOOD FLOW VELOCITY; FEMALE; HUMANS; IMAGING, THREE-DIMENSIONAL; LASER-DOPPLER FLOWMETRY; MIDDLE AGED; PROSPECTIVE STUDIES; ULTRASONOGRAPHY, DOPPLER, COLOR; UTERINE CERVICAL NEOPLASMS;

EID: 4444347826     PISSN: 09607692     EISSN: None     Source Type: Journal    
DOI: 10.1002/uog.1703     Document Type: Article

References (34)

1. Scappaticci FA. Mechanisms and future directions for angiogenesis-based cancer therapies. J Clin Oncol 2002; 20: 3906-3927.
2. Taylor KJW, Ramos I, Carter D, Morse SS, Snower D, Fortune K. Correlation of Doppler US tumor signals with neovascular morphologic features. Radiology 1988; 166: 57-62.
3. Kidron D, Bernheim J, Aviram R, Cohen I, Fishman A, Beyth Y, Tepper R. Resistance to blood flow in ovarian tumors: correlation between resistance index and histological pattern of vascularization. Ultrasound Obstet Gynecol 1999; 13: 425-430.
4. Valentin L. Gray scale sonography, subjective evaluation of the color Doppler image and measurement of blood flow velocity for distinguishing benign and malignant tumors of suspected adnexal origin. Eur J Obstet Gynecol 1997; 72: 63-72.
5. Salem S, White LM, Lai J. Doppler sonography of adnexal masses: the predictive value of the pulsatility index in benign and malignant disease. AJR Am J Roentgenol 1994; 163: 1147-1150.
6. Levine D, Feldstein VA, Babcook CJ, Filly RA. Sonography of ovarian masses: poor sensitivity of resistive index for identifying malignant lesions. AJR Am J Roentgenol 1994; 162: 1355-1359.
7. Testa AC, Ciampelli M, Mastromarino C, Lopez R, Zannoni G, Ferrandina G, Scambia G. Intratumoral color Doppler analysis in endometrial carcinoma: is it clinically useful? Gynecol Oncol 2003; 88: 298-303.
8. Alcazar JL, Galan MJ, Jurado M, Lopez-Garcia G. Intratumoral blood flow analysis in endometrial carcinoma: correlation with tumor characteristics and risk for recurrence. Gynecol Oncol 2002; 84: 258-262.
9. Lee CN, Cheng WF, Chen CA, Chu JS, Hsieh CY, Hisieh FJ. Angiogenesis and endometrial carcinomas assessed by measurement of intratumoral blood flow, microvessel density, and vascular endothelial growth factor levels. Obstet Gynecol 2000; 96: 615-621.
10. Hata T, Hata K, Senoh D, Makihara K, Aoki S, Takamiya O, Kitao M. Doppler ultrasound assessment of tumor vascularity in gynaecologic disorders. J Ultrasound Med 1989; 8: 309-314.
11. Hsieh CY, Wu CC, Chen TM, Chen CA, Chen CL, Wang JF, Chang CF, Hsieh FJ. Clinical significance of intratumoral blood flow in cervical carcinoma assessed by color Doppler ultrasound. Cancer 1995; 75: 2518-2522.
12. Tepper R, Zalel Y, Altaras M, Ben-Baruch G, Beyth Y. Transvaginal color Doppler ultrasound in the assessment of invasive cervical carcinoma. Gynecol Oncol 1996; 60: 26-29.
13. Carter JR. Cervical tumor characterization by transvaginal color flow Doppler ultrasound. Int J Gynecol Cancer 1999; 9: 279-284.
14. Cheng WF, Wei LH, Su YN, Cheng SP, Chu JS, Lee CN. The possible role of color flow Doppler in planning treatment in early invasive carcinoma of the cervix. Br J Obstet Gynaecol 1999; 160: 1137-1142.
15. Cheng WF, Lee CN, Chu JS, Chen CA, Chen TM, Shau WY, Hsieh CY, Hsieh FJ. Vascularity index as a novel parameter for the in vivo assessment of angiogenesis in patients with cervical carcinoma. Cancer 1999; 85: 651-657.
16. Wu Y, Yuan C, Hung J, Chao K, Yen M, Ng H. Power Doppler angiographic appearance and blood flow velocity waveforms in invasive cervical carcinoma. Gynecol Oncol 2000; 79: 181-186.
17. Alcazar JL, Castillo G, Jurado M, Lopez-Garcia G. Intratumoral blood flow in cervical cancer as assessed by transvaginal color Doppler ultrasonography: Correlation with tumor characteristics. Int J Gynecol Cancer 2003; 13: 510-514.
18. Testa AC, Ferrandina G, Mansueto D, Basso D, Mastromarino C, Lopez R, Scambia G. Angio power 3D quantitative analysis in gynecological tumors: applicability and reproducibility. New York 2-7 Nov 2002: Abstract O85. Ultrasound Obstet Gynecol 2002; 20 (Suppl 1): 26.
19. Jarvela IY, Sladkevidus P, Tekay AH, Campbell S, Nargund G. Intraobserver and interobserver variability of ovarian volume, gray-scale and color flow indices obtained using transvaginal three-dimensional power Doppler ultrasonography. Ultrasound Obstet Gynecol 2003; 21: 277-282.
20. Pairleitner H, Steiner H, Hasenoehrl G and Staudach A. Three-dimensional power Doppler sonography: imaging and quantifying blood flow and vascularization. Ultrasound Obstet Gynecol 1999; 14: 139-143.
21. Scambia G, Benedetti Panici P, Foti E, Amoroso M, Salerno G, Ferrandina G, Battaglia F, Greggi S, De Gaetano A, Puglia G, Mancuso S. Squamous cell carcinoma antigen: prognostic significance and role in the monitoring of neoadjuvant chemotherapy response in cervical cancer. J Clin Oncol 1994; 12: 2309-2316.
22. Strauss HG, Laban C, Lautenschläger C, Buchmann, Schneider I, Koelbl H. SCC antigen in the serum as an independent prognostic factor in operable squamous cell carcinoma of the cervix. Eur J Cancer 2002; 38: 1987-1991.
23. Williams CS, DuBois RN. Prostaglandins endoperoxide synthase: why two isoforms? Am J Physiol 1996; 270: 393-400.
24. Ferrandina G, Lauriola L, Di Stefano MG, Zannoni GF, Gessi M, Legge F, Maggiano N, Mancuso S, Capelli A, Scambia G, Ranelletti FO. Increased cyclooxygenase-2 (cox-2) expression is associated with chemotherapy resistance and poor survival in cervical cancer patients. J Clin Oncol 2002; 20: 973-981.
25. Creasman WT. New gynecologic cancer staging. Gynecol Oncol 1995; 58: 157-158.
26. Timmerman D, Valentin L, Bourne TH, Collins WP, Verreist H, Vergote I. Terms, definitions and measurements to describe the sonographic features of adnexal tumors: a consensus opinion from the International Ovarian Tumor Analysis (IOTA) Group. Ultrasound Obstet Gynecol 2000; 16: 500-505.
27. Pourcelot L. Application clinique de l'examen Doppler transcutanie. In Velocimetric Ultrasonor Doppler, Perroneau P (ed.). INSERM: Paris, 1974; 34: 625-637.
28. Testa AC, Mansueto D, Lorusso D, Fruscella E, Basso D, Scambia G, Ferrandina G. Angio power three-dimensional quantitative analysis in gynecologic solid tumors: feasibility and reproducibility. J Ultrasound Med 2004; 23: 821-828.
29. Ferrandina G, Lauriola L, Zannoni GF, Distefano M, Legge F, Salutari V, Gessi M, Maggiano N, Scambia G, Ranelletti FO. Expression of cyclooxygenase-2 (COX-2) in tumor and stroma compartments in cervical cancer: clinical implications. Br J Cancer 2002; 87: 1145-1152.
30. Cheng WF, Chen TM, Chen CA, Wu CC, Huang KT, Hsieh CY, Hsieh FJ. Clinical application of intratumoral blood flow study in patients with endometrial carcinoma. Cancer 1998; 82: 1881-1886.
31. Hata K, Yoshida M, Maruyama R, Fujiwaki R, Miyazaki K. Prognostic significance of ultrasound derived intratumoral peak systolic velocity in epithelial ovarian cancer. Ultrasound Obstet Gynecol 2002; 20: 186-191.
32. TM imaging: a new method to assess intracervical vascularization in benign and pathological conditions. Ultrasound Obstet Gynecol 1998; 11: 133-137.
33. Ferrandina G, Ranelletti FO, Legge F, Lauriola L, Salutari V, Gessi M, Testa AC, Werner U, Navarra P, Tringali G, Battaglia A, Scambia G. Celecoxib modulates the expression of cyclooxygenase-2, Ki67, apoptosis-related marker, and microvessels density in human cervical cancer: a pilot study. Clin Cancer Research 2003; 9: 4324-4331.
34. Foster FS, Burns PN, Simpson DH, Wilson SR, Christopher DA, Go DE. Ultrasound for the visualization and quantification of tumor microcirculation. Cancer Metastasis Rev 2000; 19: 131-138.